| Primary information |
|---|
| sequence ID | Seq_2665 |
| Peptide sequence | GGEGKGGSDGGGSHRKEGEEADAPGVIPG |
| CancerPDF_ID | CancerPDF_ID3501, |
| PMID | 27026199 |
| Protein Name | CD99 antigen |
| UniprotKB Entry Name | CD99_HUMAN |
| Fluid | Urine |
| fdr | 2663.22 |
| Profiling Technique | "CE-MS, Micro-TOF-MS" |
| Peptide Identification technique | MS-MS |
| Labelled/Label Free | Label Free |
| CancerPDF_ID | CancerPDF_ID3501, |
| p-Value | less than 0.05 |
| Software | Proteome Discoverer 1.2 |
| Length | 29 |
| Cancer Type | Bladder cancer |
| Database | Uniprot Human non-redundant Database |
| Modification | NA |
| Number of Patients | 451 for training (341 patients and 110 normal) and 270 for testing(168 primary UBC patients and 102 normal controls); |
| Regulation | Differentially expressed between primary UBC and normal individual |
| Validation | Independent Validation |
| Sensitivity | For testing dataset 91% |
| Specificity | For testing dataset 68% |
| Accuracy | For testing dataset 76% |
| Peptide Atlas | NA |
| IEDB | NA |